Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pemigatinib is indicated for adult patients with advanced, metastatic, or unrese···【more】
Release date：2024-08-13Recommended：294
Pemigatinib is an innovative targeted therapy that provides a new treatment opti···【more】
Release date：2024-08-13Recommended：322
Pemigatinibis mainly used to treat specific diseases such as advanced or metasta···【more】
Release date：2024-08-13Recommended：314
Pemigatinib is used in adults to treat bile duct cancer that has spread to other···【more】
Release date：2024-08-13Recommended：290
Pemigatinib is a targeted therapy drug developed by Incyte in the United States,···【more】
Release date：2024-08-12Recommended：282
Venetoclax is a drug used to treat leukemias, specifically chronic lymphocytic l···【more】
Release date：2024-08-09Recommended：345
Venetoclax is a BCL-2 inhibitor that selectively binds to BCL-2 protein and inhi···【more】
Release date：2024-08-09Recommended：299
Pemigatinib is a potent and selective oral antineoplastic drug targeting the FGF···【more】
Release date：2024-08-09Recommended：247
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed i···【more】
Release date：2024-08-09Recommended：203
Venetoclax is a drug used to treat chronic lymphocytic leukemia (CLL) and certai···【more】
Release date：2024-08-09Recommended：329
Capmatinib is a targeted drug manufactured by Novartis for the treatment of pati···【more】
Release date：2024-08-09Recommended：360
Capmatinib, trade name Tabrecta. It is an oral MET inhibitor mainly used for the···【more】
Release date：2024-08-09Recommended：335
